|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 4/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
164,320,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $0.8281 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ViewRay designs, manufactures and markets the ViewRay MRIdian® MRI-Guided Radiation Therapy System. MRIdian is built upon a proprietary magnetic resonance imaging (MRI) system to address the challenges and clinical workflow for radiation oncology. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic-quality MRI with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. Co.'s generations of the MRIdian are: the MRIdian with Cobalt-60 based radiation beams and MRIdian Linac, with linear accelerator or linac based radiation beams.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
71,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$252,506 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
4 |
| Total Shares Sold |
0 |
0 |
13,487,227 |
13,529,227 |
| Total Sell Value |
$0 |
$0 |
$844,275 |
$1,017,735 |
| Total People Sold |
0 |
0 |
8 |
9 |
| Total Sell Transactions |
0 |
0 |
11 |
12 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Drake Scott William |
President & CEO |
• • – |
2022-10-24 |
4 |
D |
$4.16 |
$307,973 |
D/D |
(74,032) |
3,921,310 |
|
- |
|
| Mccormack Robert S |
SVP Gen Counsel & Corp Sec |
• – – |
2022-10-24 |
4 |
D |
$4.16 |
$136,968 |
D/D |
(32,925) |
471,958 |
|
- |
|
| Ziegler Paul Jr |
Chief Commercial Officer |
• – – |
2022-10-24 |
4 |
D |
$4.16 |
$18,267 |
D/D |
(4,391) |
333,292 |
|
- |
|
| Drake Scott William |
President & CEO |
• • – |
2022-06-15 |
4 |
D |
$2.69 |
$313,116 |
D/D |
(116,400) |
3,995,342 |
|
- |
|
| Ziegler Paul Jr |
Chief Commercial Officer |
• – – |
2022-06-14 |
4 |
D |
$2.63 |
$23,147 |
D/D |
(8,801) |
337,683 |
|
- |
|
| Roberts Brian K |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
202,272 |
|
- |
|
| Johnson B Kristine |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
237,044 |
|
- |
|
| Spencer Phillip M |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
142,302 |
|
- |
|
| Wilensky Gail R |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
197,666 |
|
- |
|
| Moore Daniel Jeffrey |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
327,509 |
|
- |
|
| Castelein Caley |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
881,887 |
|
- |
|
| Prange Karen |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
138,265 |
|
- |
|
| Schnabel Susan C |
Director |
– • – |
2022-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
54,511 |
167,790 |
|
- |
|
| Dempsey James F. |
Chief Scientific OfficerOffice |
• – – |
2022-06-10 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
679,826 |
|
39% |
|
| Stassen Zachary William |
Chief Financial Officer |
• – – |
2022-06-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(50,531) |
605,832 |
|
- |
|
| Schnabel Susan C |
Director |
– • – |
2022-05-20 |
4 |
B |
$2.93 |
$58,518 |
D/D |
20,000 |
113,279 |
2.39 |
22% |
|
| Schnabel Susan C |
Director |
– • – |
2022-05-19 |
4 |
B |
$2.89 |
$28,898 |
D/D |
10,000 |
93,279 |
2.39 |
28% |
|
| Roberts Brian K |
Director |
– • – |
2022-05-18 |
4 |
B |
$2.98 |
$47,680 |
D/D |
16,000 |
147,761 |
2.39 |
28% |
|
| Johnson B Kristine |
Director |
– • – |
2022-05-12 |
4/A |
B |
$2.82 |
$112,704 |
I/I |
40,000 |
40,000 |
2.1 |
- |
|
| Johnson B Kristine |
Director |
– • – |
2022-05-12 |
4 |
B |
$2.82 |
$112,704 |
D/D |
40,000 |
222,533 |
2.39 |
27% |
|
| Schnabel Susan C |
Director |
– • – |
2022-05-12 |
4 |
B |
$2.75 |
$13,750 |
D/D |
5,000 |
83,279 |
2.39 |
27% |
|
| Castelein Caley |
Director |
– • – |
2022-05-11 |
4 |
B |
$2.54 |
$2,701,479 |
I/I |
1,065,000 |
1,545,600 |
2.1 |
62% |
|
| Drake Scott William |
President & CEO |
• • – |
2022-05-11 |
4 |
B |
$2.53 |
$295,514 |
D/D |
117,012 |
4,111,742 |
2.81 |
62% |
|
| Stassen Zachary William |
Chief Financial Officer |
• – – |
2022-05-11 |
4 |
B |
$2.49 |
$49,760 |
D/D |
20,000 |
656,363 |
2.74 |
62% |
|
| Castelein Caley |
Director |
– • – |
2022-05-10 |
4 |
B |
$2.57 |
$899,640 |
I/I |
350,000 |
480,600 |
2.1 |
52% |
|
318 Records found
|
|
Page 3 of 13 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
